PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University Bordeaux, Inserm, BPH, U1219, Team Pharmacoepidemiology, 33000 Bordeaux, France; CHU de Bordeaux, pôle de santé publique, service de pharmacologie médicale, unité de pharmaco-épidémiologie et bon usage du médicament, 33000 Bordeaux, France. Electronic address: antoine.pariente@u-bordeaux.fr.\', \'University Bordeaux, Inserm, BPH, U1219, Team Pharmacoepidemiology, 33000 Bordeaux, France; CHU de Bordeaux, pôle de santé publique, service de pharmacologie médicale, unité de pharmaco-épidémiologie et bon usage du médicament, 33000 Bordeaux, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0040-5957(21)00116-510.1016/j.therap.2021.05.002
?:hasPublicationType
?:journal
  • Therapie
is ?:pmid of
?:pmid
?:pmid
  • 34119319
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.293
?:rankingScore_hIndex
  • 32
?:title
  • Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34119319>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34119319>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all